Wall Street Zen Upgrades Longevity Health (NASDAQ:XAGE) to Hold

Longevity Health (NASDAQ:XAGE) was upgraded by investment analysts at Wall Street Zen to a “hold” rating in a report issued on Saturday.

Longevity Health Stock Performance

Shares of XAGE stock opened at $2.59 on Friday.

Longevity Health Company Profile

Carmell Therapeutics Corporation focuses on the development of plasma-based bioactive material (PBM) to stimulate tissue repair or growth after injury, disease, and aging. Its lead product candidate is CT-101 bone healing accelerant for tibia fracture healing, foot/ankle fusion, spinal fusion, dental bone graft substitute, and bone void filler; and tissue healing accelerant for androgenetic alopecia and chronic wound healing.